Skip to main content
Live Action LogoLive Action
Ben Prince-Saxon is running, wearing a blue shirt, hat, and sunglesses.
Photo: Ben Prince-Saxon (Give A Little)

Runner with cystic fibrosis completes 12 marathons in a year

Live Action News - Human Interest IconHuman Interest·By Nancy Flanders

Runner with cystic fibrosis completes 12 marathons in a year

A 25-year-old with cystic fibrosis is celebrating the completion of a year-long challenge of running 12 marathons in 12 months to raise awareness for the Cystic Fibrosis New Zealand organization. Just two years ago, he could barely exercise at all.

Key Takeaways:

  • Ben Prince-Saxon has cystic fibrosis, and two years ago, he struggled to breathe and exercise.

  • Thanks to new medications, he just completed 12 marathons in 12 months to raise awareness and funds for Cystic Fibrosis New Zealand.

  • Prince-Saxon raised over $25,000 for the organization to help patients and families.

  • The abortion rate for children diagnosed prenatally with cystic fibrosis is 94.6%, according to a 2019 study.

The Backstory:

Ben Prince-Saxon, a runner from Auckland, New Zealand, has cystic fibrosis (CF), a genetic condition that causes mucus in the body to be thick and sticky, clogging organs like the pancreas and lungs and making it difficult to breathe. Managing the condition involves twice-daily airway clearance therapies and multiple medications.

Medical advancements have helped extend the median predicted age of survival of those with CF from early childhood in the 1950s to age 65 for those born between 2020 and 2024. But a cure is still needed for everyone with CF, and Prince-Saxon set out to help make that happen... and to show what's possible when living with CF.

"I have cystic fibrosis (CF), a condition that impacts my lungs and limits my daily life in many ways — but it won't stop me from achieving this," he wrote on this Give A Little fundraising page. "This year, I've set myself an enormous challenge: running 12 marathons in 12 months. This goal isn't just about pushing my limits; it's about raising awareness and crucial funds for Cystic Fibrosis New Zealand (CFNZ)."

The Details:

Prince-Saxon was looking to raise $25,000 and exceeded that goal, raising $25,720. He ran the final marathon of his challenge on December 7.

“It was an unreal feeling, something I’ve never felt before in my life,” he told Stuff about finishing his final run. “I’m extremely proud and extremely grateful, two years ago I never would have been able to imagine doing something like this, it’s amazing.”

Previously, Prince-Saxon struggled to exercise, but after beginning Trikafta, one of several newly-developed medications for people with CF, his health improved dramatically. Trikafta — along with Symdeko, Orkambi, Kalydeco, and Alyftrek — directly targets the faulty CFTR protein that causes CF.

Article continues below

Dear Reader,

In 2026, Live Action is heading straight where the battle is fiercest: college campuses.

We have a bold initiative to establish 100 Live Action campus chapters within the next year, and your partnership will make it a success!

Your support today will help train and equip young leaders, bring Live Action’s educational content into academic environments, host on-campus events and debates, and empower students to challenge the pro-abortion status quo with truth and compassion.

Invest in pro-life grassroots outreach and cultural formation with your DOUBLED year-end gift!

“My life has changed drastically. I now run for fun and to better my health,” said Prince-Saxon. “Two years ago before I started Trikafta I could barely get through a sentence without breaking down coughing; it’s been amazing.”

Simone Brown, executive lead of CFNZ, said, "Ben has turned a personal journey into something that's lifting an entire community. Every kilometre he has run helps make cystic fibrosis visible, and every dollar raised means more wrap-around support for Kiwis who are navigating a demanding condition every day."

Now that the marathon challenge is complete, Prince-Saxon has a new goal in front of him: to become the fastest person with CF to complete a marathon.

The Bottom Line:

Tragically, parents of children who are diagnosed with CF while still in the womb often face pressure to have abortions.

In research published in 2019, a 94.6% abortion rate was found when testing showed two pathogenic variants in a baby whose parents were both carriers of CF. The abortion rate is 65% for babies who received a CF diagnosis based on an intestinal blockage detected during an ultrasound.

"[Abortion] and caring for a child with CF were both associated with poor short-term parental psychological outcomes," researchers wrote. "Ethical analyses indicated that informed decisions should have been the main endpoint, rather than CF-affected births prevented."

Live Action News is pro-life news and commentary from a pro-life perspective.

Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.

Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!

Read Next

Read NextBIRMINGHAM, ENGLAND - JULY 30: Jack Osbourne, Sharon Osbourne, Kelly Osbourne and family members stop to view tributes to the late Ozzy Osbourne from fans at Black Sabbath Bench and Bridge as his funeral cortege travels through his home city of Birmingham on July 30, 2025 in Birmingham, England. The Black Sabbath frontman passed away on July 22nd at the age of 76. His death occurred just a little over two weeks after his final live performance at the 'Back to the Beginning' concert in his hometown of Birmingham.
Pop Culture

Sharon Osbourne says her kids and grandkids are 'the reason' she's still alive

Cassy Cooke

·

Spotlight Articles